Nuveen Asset Management, LLC Sigilon Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $1.64 $16,741 - $37,103	-22,624 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.58 - $6.13 $10,637 - $25,273	-4,123 Reduced 15.41%	22,624 $57,000
Q3 2021 Nov 12, 2021	BUY	$4.42 - $10.61 $10,537 - $25,294	2,384 Added 9.79%	26,747 $163,000
Q2 2021 Aug 16, 2021	BUY	$9.15 - $20.17 $108,555 - $239,296	11,864 Added 94.92%	24,363 $261,000
Q1 2021 May 17, 2021	BUY	$18.76 - $40.91 $234,481 - $511,334	12,499 New	12,499 $279,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.